Expansion of hematopoietic stem/progenitor cells

Area of Science:

• Hematology
• Stem Cell Biology
• Cell Therapy

Background:

• Hematopoietic stem/progenitor cells (HSPCs) transplantation is vital for treating various diseases.
• A significant limitation is the scarcity of HSPCs in collected samples, hindering effective transplantation.

Purpose of the Study:

• To review current and emerging strategies for expanding HSPCs in vitro.
• To discuss the molecular mechanisms and clinical implications of HSPC expansion.

Main Methods:

• Review of established in vitro expansion protocols including cytokine cocktails, co-culture systems, and bioreactors.
• Exploration of novel approaches targeting transcription, cell cycle, telomerase, and chromatin modification.
• Discussion of clinical applicability and safety considerations for expanded HSPCs.

Main Results:

• Multiple methods exist for in vitro HSPC expansion, with ongoing advancements.
• Emerging strategies leverage deeper understanding of molecular regulation for enhanced expansion.
• Clinical translation requires careful evaluation of safety and efficacy.

Conclusions:

• In vitro expansion of HSPCs is essential for overcoming cell number limitations in transplantation.
• Progress in understanding cellular mechanisms drives innovative expansion techniques.
• Further research is needed to ensure the safety and efficacy of expanded HSPCs for clinical use.